Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma

Abstract

The prognosis and immunotherapy response rates are unfavorable in patients with oral squamous cell carcinoma (OSCC). The tumor microenvironment is associated with tumor prognosis and progression, and the underlying mechanisms remain unclear. We obtained differentially expressed immune-related genes from OSCC mRNA data in The Cancer Genome Atlas (TCGA) database. Overall survival-related risk signature was constructed by univariate Cox regression analysis and LASSO Cox regression analysis. The prognostic performance was validated with receiver operating characteristic (ROC) analysis and Kaplan–Meier survival curves in the TCGA and Gene Expression Omnibus (GEO) datasets. The risk score was confirmed to be an independent prognostic factor and a nomogram was built to quantify the risk of outcome for each patient. Furthermore, a negative correlation was observed between the risk score and the infiltration rate of immune cells, as well as the expression of immunostimulatory and immunosuppressive molecules. Functional enrichment analysis between different risk score subtypes detected multiple immune-related biological processes, metabolic pathways, and cancer-related pathways. Thus, the immune-related gene signature can predict overall survival and contribute to the personalized management of OSCC patients.

A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients

“…The ROC curve of 7 IRGs predicting the 1-year overall survival rate of oral cancer provided the AUC value was 0.660 [23]. Another IRGs signature in oral squamous cell carcinoma predicting the one-year overall survival rate of oral cancer provided the AUC value as 0.753 [24]. These values were lower than our model value as 0.774.…”